SCHEMBL845005

SCHEMBL845005

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3OCc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccc1OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
HSD17B10 Q99714 1/20 0.51
NPSR1 Q6W5P4 1/20 0.50
KDM1A O60341 1/20 0.50
RCOR1 Q9UKL0 1/20 0.50
APP P05067 5/20 0.49
TSHR P16473 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALDH1A1 P00352 3/20 0.48
GAA P10253 2/20 0.47
PABPC1 P11940 1/20 0.47
SGMS2 Q8NHU3 1/20 0.47
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873465 0.92 KDM4E (0.47) KDM4ELMNAHSD17B10NPSR1KDM1A
SCHEMBL845312 0.89 GAA (0.60) KDM4ELMNATSHRL3MBTL1ALDH1A1
SCHEMBL845503 0.88 SGMS2 (0.52) KDM4ELMNAHSD17B10NPSR1KDM1A
SCHEMBL845060 0.87 KDM4E (0.51) KDM4ELMNAHSD17B10NPSR1KDM1A
SCHEMBL845518 0.87 GAA (0.52) KDM4ELMNATSHRL3MBTL1ALDH1A1
SCHEMBL845021 0.86 ALDH1A1 (0.53) KDM4ELMNANPSR1TSHRALDH1A1
SCHEMBL845284 0.85 MAPK1 (0.58) LMNANPSR1ALDH1A1GAAPABPC1
SCHEMBL845353 0.85 KDM4E (0.52) KDM4ELMNAHSD17B10NPSR1KDM1A
SCHEMBL845392 0.83 ALDH1A1 (0.51) KDM4ELMNAHSD17B10KDM1ARCOR1
SCHEMBL845355 0.83 ALDH1A1 (0.50) KDM4ELMNAHSD17B10KDM1ARCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed